Compliance of patients and physicians: experience and lessons from tuberculosis-II.
作者信息
Fox W
出版信息
Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):101-5. doi: 10.1136/bmj.287.6385.101.
Abstract
摘要
相似文献
1
Compliance of patients and physicians: experience and lessons from tuberculosis-II.患者与医生的依从性：结核病防治的经验与教训（二）
Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):101-5. doi: 10.1136/bmj.287.6385.101.
2
Short-course chemotherapy for tuberculosis.
Lancet. 1979 Aug 25;2(8139):420. doi: 10.1016/s0140-6736(79)90432-x.
3
Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.在一项针对涂片阳性肺结核的三种6个月治疗方案的对照试验中，对异烟肼、利福平及吡嗪酰胺每日联合制剂的评估。新加坡结核病防治所/英国医学研究委员会
Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):707-12. doi: 10.1164/ajrccm/143.4_Pt_1.707.
4
Short-course chemotherapy for pulmonary tuberculosis. Points of interest.肺结核的短程化疗。关注点。
S Afr Med J. 1982 Jun 5;61(23):867-70.
5
Modern treatment of tuberculosis.结核病的现代治疗
Compr Ther. 1982 Sep;8(9):19-28.
6
7
Tuberculosis treatment: dangerous regimens?结核病治疗：危险的治疗方案？
Int J Tuberc Lung Dis. 2001 Jan;5(1):1-3.
8
Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.对痰涂片阳性肺结核患者采用每周三次、为期6个月的治疗方案，比较2个月、4个月和6个月吡嗪酰胺使用时间的对照试验，包括对异烟肼、利福平及吡嗪酰胺复方制剂的评估。30个月时的结果。香港胸科服务处/英国医学研究委员会
Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):700-6. doi: 10.1164/ajrccm/143.4_Pt_1.700.
9
What's new in tuberculosis?结核病有哪些新进展？
Am J Med. 1981 Jul;71(1):1-4. doi: 10.1016/0002-9343(81)90249-7.
10
[Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].[肺结核的间歇化疗（文献综述）]
Probl Tuberk. 1978 Oct(10):23-8.
引用本文的文献
1
Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis.抗结核治疗不依从在埃塞俄比亚的流行情况及其决定因素：系统评价和荟萃分析。
PLoS One. 2019 Jan 10;14(1):e0210422. doi: 10.1371/journal.pone.0210422. eCollection 2019.
2
Non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment.新确诊肺结核患者对抗结核治疗的不依从性。
Ann Med Health Sci Res. 2013 Jan;3(1):67-74. doi: 10.4103/2141-9248.109507.
3
The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia.有效公共结核病治疗的价值：拉脱维亚耐多药结核病相关机会成本分析。
Cost Eff Resour Alloc. 2013 Apr 17;11(1):9. doi: 10.1186/1478-7547-11-9.
4
Does directly observed therapy (DOT) reduce drug resistant tuberculosis?直接观察治疗（DOT）是否能降低耐药结核病的发生率？
BMC Public Health. 2011 Jan 7;11:19. doi: 10.1186/1471-2458-11-19.
5
Paradoxical response to antitubercular drugs.对抗结核药物的矛盾反应。
Indian J Pediatr. 1995 Nov-Dec;62(6):695-701. doi: 10.1007/BF02825120.
6
Directly observed therapy (DOT) for tuberculosis: why, when, how and if?结核病的直接观察治疗（DOT）：为何、何时、如何以及是否采用？
Thorax. 1999 Aug;54 Suppl 2(Suppl 2):S42-5. doi: 10.1136/thx.54.2008.s42.
7
Trends in tuberculosis.结核病的趋势
Postgrad Med J. 1984 Mar;60(701):187-93. doi: 10.1136/pgmj.60.701.187.
8
Treatment of tuberculosis.结核病的治疗。
Br Med J (Clin Res Ed). 1985 Aug 24;291(6494):497-8. doi: 10.1136/bmj.291.6494.497.
9
Small intestinal bacterial overgrowth in patients with chronic lymphocytic leukaemia.慢性淋巴细胞白血病患者的小肠细菌过度生长
J Clin Pathol. 1990 Jan;43(1):57-9. doi: 10.1136/jcp.43.1.57.
10
Orocaecal transit time in Duchenne muscular dystrophy.杜氏肌营养不良症中的口盲肠转运时间。
Arch Dis Child. 1991 Jan;66(1):143-4. doi: 10.1136/adc.66.1.143.
本文引用的文献
1
Behavioral engineering: the use of response priming to improve prescribed self-medication.行为工程学：利用反应启动来改善规定的自我药物治疗。
J Appl Behav Anal. 1969 Spring;2(1):39-42. doi: 10.1901/jaba.1969.2-39.
2
A NEW METHOD FOR THE DETERMINATION OF N-ACETYL ISONIAZID IN URINE OF AMBULATORY PATIENTS.一种测定门诊患者尿液中N-乙酰异烟肼的新方法。
Am Rev Respir Dis. 1964 Apr;89:587-8. doi: 10.1164/arrd.1964.89.4.587.
3
Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 3. Serum concentrations of isoniazid produced by three regimens of isoniazid alone and one of isoniazid plus PAS.南印度肺结核患者中异烟肼的失活率。3. 三种单用异烟肼方案及一种异烟肼加对氨基水杨酸方案所产生的异烟肼血清浓度。
Bull World Health Organ. 1961;25(6):793-806.
4
Self-administration of medicaments. A review of published work and a study of the problems.
Bull Int Union Tuberc. 1962 Jul;32:307-31.
5
The problem of self-administration of drugs; with particular reference to pulmonary tuberculosis.药物自我给药问题；特别涉及肺结核。
Tubercle. 1958 Oct;39(5):269-74. doi: 10.1016/s0041-3879(58)80088-4.
6
Outpatient P.A.S. therapy.门诊P.A.S. 疗法
Lancet. 1957 Nov 2;273(7001):871-2. doi: 10.1016/s0140-6736(57)90006-5.
7
Simple tests for the detection of urinary PAS.用于检测尿中对氨基水杨酸的简单测试。
Tubercle. 1956 Oct;37(5):333-40. doi: 10.1016/s0041-3879(56)80079-2.
8
Staffing in thoracic medicine.胸科医学的人员配备
Br Med J. 1980 Sep 27;281(6244):887-8. doi: 10.1136/bmj.281.6244.887.
9
American Thoracic Society. Medical Section of the American Lung Association. Guidelines for short-course tuberculosis chemotherapy.美国胸科学会。美国肺脏协会医学部。短程结核病化疗指南。
Am Rev Respir Dis. 1980 Mar;121(3):611-4.
10
A medication monitor and fluorescein technique designed to study medication behaviour.一种用于研究药物行为的药物监测器和荧光素技术。
Acta Ophthalmol (Copenh). 1980 Jun;58(3):459-67. doi: 10.1111/j.1755-3768.1980.tb05747.x.
Zotero 插件